Even though respiratory infections and conditions have already been described as contraindications for HBOT, the case of SARS-CoV-two is undoubtedly an exception. These days, the likely utilization of HBOT from the COVID-19 has become specially regarded, exposing brings about many managed clinical trials. Furthermore, the usage of this course of ac